The relationship between mTOR pathway activation and epilepsy has been first implicated in genetic epilepsy using transgenic knockout mouse models of tuberous sclerosis complex and PTEN [5,6], and has also been examined in acquired epilepsy in animal models of temporal lobe epilepsy induced by kainic acid (KA) or pilocarpine [7,8]. This evidence concerns the gene MTOR and epilepsy.